PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-08

Date Title Company
08-Sep-2022 Global Drug Delivery Solutions Market Report 2022: Key Drivers, Players and Forecasts to 2031 - ResearchAndMarkets.com Businesswire
08-Sep-2022 Founder of Aurora Cannabis Terry Booth, Joins Akanda as Chair of Advisory Board Businesswire
08-Sep-2022 Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout Businesswire
08-Sep-2022 Global Cell Therapy Manufacturing Market 2022: Advancing Biopharmaceutical Industries Bodes Well for Sector - ResearchAndMarkets.com Businesswire
08-Sep-2022 IgniteData joins strategic Vulcan HL7 FHIR Accelerator collaboration IgniteData
08-Sep-2022 Shields Health Solutions to Present Clinical Research Posters on Integrated Specialty at NASP Annual Meeting & Expo and Impanel Health System Partners during Pre-Conference Hospital Workshop Businesswire
08-Sep-2022 Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies Businesswire
08-Sep-2022 Innoviva to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Businesswire
08-Sep-2022 KalVista Pharmaceuticals Reports First Fiscal Quarter Results Businesswire
08-Sep-2022 Osmol Therapeutics Announces Appointment of Teresa Bitetti, President, Global Oncology Business Unit at Takeda Pharmaceuticals, to the Board of Directors Businesswire
08-Sep-2022 Bicara Therapeutics to Host Webinar to Review Latest Clinical Trial Data for BCA101 Businesswire
08-Sep-2022 Revance Announces FDA Approval of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection, the First and Only Peptide-Formulated Neuromodulator With Long-Lasting Results Businesswire
08-Sep-2022 Selexis and NexImmune Sign Service Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers and Autoimmune Disorders Businesswire
08-Sep-2022 Global Lung Injury Market Report (2022 to 2027) - Featuring Bayer, General Electric and Medtronic Among Others - ResearchAndMarkets.com Businesswire
08-Sep-2022 Resumen: Los estudios demuestran la eficacia de AJOVY®▼ (fremanezumab) para el tratamiento de la migraña en pacientes con depresión comórbida Businesswire
08-Sep-2022 Riassunto: Due studi dimostrano l'efficacia di AJOVY®▼ (fremanezumab) per il trattamento dell'emicrania in pazienti con depressione associata Businesswire
08-Sep-2022 Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Molecules for Precision Phosphorylation to Modulate and Repair Disease-Driving Proteins Businesswire
08-Sep-2022 European pharmaceutical recalls increase by 19% Sedgwick
08-Sep-2022 Global Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Report 2022 - ResearchAndMarkets.com Businesswire
08-Sep-2022 The Worldwide Analytical Laboratory Services Industry is Projected to Reach $1.6 Billion by 2027 - ResearchAndMarkets.com Businesswire